Press Releases Items Per Page 102550 Year None2023202220212020201920182017201620152014201320122011201020092008 September 1, 2021 Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery August 5, 2021 Revance Reports Second Quarter 2021 Financial Results, Provides Corporate Update July 29, 2021 Revance to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021 May 26, 2021 Revance to Participate in Upcoming Virtual Healthcare Conferences May 26, 2021 Revance Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection May 10, 2021 Revance Reports First Quarter 2021 Financial Results, Provides Corporate Update May 3, 2021 Revance to Release First Quarter 2021 Financial Results on Monday, May 10, 2021 April 27, 2021 Revance to Showcase Clinical Findings at The Aesthetic Meeting 2021 that Supports DaxibotulinumtoxinA’s 24-Week Long Duration Profile Across Multiple Female Age Cohorts April 27, 2021 Revance Announces First Patient Enrolled for DaxibotulinumtoxinA in Glabellar Lines and Cervical Dystonia in China by Fosun Pharma April 23, 2021 Revance to Present Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Fillers at American Academy of Dermatology VMX Meeting 2021 Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page next › Last page last » Displaying 51 - 60 of 305
